Cipla Limited (CIPLA) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE059A01026
Key metrics
- Market Cap
- ₹1.12 L Cr
- P/E Ratio
- 33.21
- EPS
- 41.7
- Book Value
- 427.35
- P/B Ratio
- 3.27
- ROE
- 11.24%
- ROCE
- 13.79%
- Debt / Equity
- 0.02
- Net Margin
- 14%
- Revenue Growth
- 2.09%
- Profit Growth
- -26.43%
- Dividend Yield
- 0.93%
- 52W High
- ₹1,673.00
- 52W Low
- ₹1,165.70
- Market Cap Band
- large cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Cipla Limited
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 31,369
- Promoter Holding
- 31.13%
The full Cipla Limited analysis
Create a free account to open the complete CIPLA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.